Intro

This chapter examines research on the prevalence of IGLON5 antibodies in patients with idiopathic REM Sleep Behavior Disorder. The discussion highlights the importance of these findings for the treatment of patients with sleep and movement disorders and their potential links to early synucleinopathies.